- Home
- SUPN vs LSPD Comparison
SUPN vs LSPD Comparison
Compare SUPN & LSPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- LSPD
- Stock Information
- Founded
- SUPN 2005
- LSPD 2005
- Country
- SUPN United States
- LSPD Canada
- Employees
- SUPN N/A
- LSPD N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- LSPD
- Sector
- SUPN Health Care
- LSPD
- Exchange
- SUPN Nasdaq
- LSPD Nasdaq
- Market Cap
- SUPN 2.1B
- LSPD 2.2B
- IPO Year
- SUPN 2012
- LSPD 2020
- Fundamental
- Price
- SUPN $33.05
- LSPD $13.16
- Analyst Decision
- SUPN Hold
- LSPD Buy
- Analyst Count
- SUPN 2
- LSPD 14
- Target Price
- SUPN $36.00
- LSPD $17.29
- AVG Volume (30 Days)
- SUPN 464.2K
- LSPD 998.0K
- Earning Date
- SUPN 02-25-2025
- LSPD 02-06-2025
- Dividend Yield
- SUPN N/A
- LSPD N/A
- EPS Growth
- SUPN 130.79
- LSPD N/A
- EPS
- SUPN 1.07
- LSPD N/A
- Revenue
- SUPN $651,972,000.00
- LSPD $1,053,623,000.00
- Revenue This Year
- SUPN $7.94
- LSPD $23.29
- Revenue Next Year
- SUPN N/A
- LSPD $18.47
- P/E Ratio
- SUPN $31.70
- LSPD N/A
- Revenue Growth
- SUPN 6.79
- LSPD 22.05
- 52 Week Low
- SUPN $25.53
- LSPD $11.01
- 52 Week High
- SUPN $40.28
- LSPD $18.96
- Technical
- Relative Strength Index (RSI)
- SUPN 32.98
- LSPD 38.27
- Support Level
- SUPN $32.53
- LSPD $13.21
- Resistance Level
- SUPN $39.99
- LSPD $14.03
- Average True Range (ATR)
- SUPN 1.31
- LSPD 0.51
- MACD
- SUPN -0.69
- LSPD 0.04
- Stochastic Oscillator
- SUPN 6.71
- LSPD 48.38
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About LSPD Lightspeed Commerce Inc. Subordinate Voting Shares
Lightspeed Commerce Inc provides an omni-channel commerce-enabling SaaS platform. Its software platform provides customers with the functionality it needs to engage with consumers, manage their operations, accept payments, and grow their businesses. The company sells its platform through a direct sales force in the United States, Canada, New Zealand, United Kingdom, Australia, Germany, and other countries. It derives a majority of its revenue from the United States.